This is partly due to obesity and unhealthy lifestyles [48] and partly to the cardiotoxicity of oncologic treatments (i.e., anthracyclines, left-side breast radiation, trastuzumab, aromatase inhibitors). The gene discussed is CYP19A1; the disease is obesity disorder.